Cathay Biotech Inc.
688065.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥22,585 | CN¥31,987 | CN¥35,694 | CN¥54,703 |
| - Cash | CN¥5,347 | CN¥5,390 | CN¥6,295 | CN¥9,629 |
| + Debt | CN¥1,860 | CN¥1,776 | CN¥1,127 | CN¥744 |
| Enterprise Value | CN¥19,099 | CN¥28,372 | CN¥30,527 | CN¥45,818 |
| Revenue | CN¥2,958 | CN¥2,114 | CN¥2,441 | CN¥2,363 |
| % Growth | 39.9% | -13.4% | 3.3% | – |
| Gross Profit | CN¥836 | CN¥579 | CN¥829 | CN¥837 |
| % Margin | 28.3% | 27.4% | 34% | 35.4% |
| EBITDA | CN¥680 | CN¥451 | CN¥672 | CN¥668 |
| % Margin | 23% | 21.3% | 27.5% | 28.3% |
| Net Income | CN¥489 | CN¥367 | CN¥553 | CN¥595 |
| % Margin | 16.5% | 17.3% | 22.7% | 25.2% |
| EPS Diluted | 0.84 | 0.63 | 0.95 | 1.43 |
| % Growth | 33.3% | -33.7% | -33.6% | – |
| Operating Cash Flow | CN¥821 | CN¥569 | CN¥804 | CN¥594 |
| Capital Expenditures | -CN¥843 | -CN¥1,570 | -CN¥4,198 | -CN¥1,475 |
| Free Cash Flow | -CN¥22 | -CN¥1,000 | -CN¥3,395 | -CN¥880 |